Gyre Therapeutics Inc Forecast, price target & analysts
Gyre Therapeutics Inc Target price 2026 - Analyst rating & recommendation
Gyre Therapeutics Inc Classifications & Recommendation
Gyre Therapeutics Inc Price Target
| Target Price | $18.36 |
| Price | $7.11 |
| Potential |
158.23%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target Gyre Therapeutics Inc 2027 .
The average Gyre Therapeutics Inc target price is $18.36.
This is
158.23%
register free of charge
$21.00
195.36%
register free of charge
$18.18
155.70%
register free of charge
|
|
| A rating was issued by 9 analysts: 8 Analysts recommend Gyre Therapeutics Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Gyre Therapeutics Inc stock has an average upside potential 2027 of
158.23%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2031
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 116.59 | 111.69 |
| 10.24% | 4.20% | |
| EBITDA Margin | 11.98% | -53.70% |
| 28.73% | 548.17% | |
| Net Margin | 4.31% | -35.83% |
| 62.26% | 930.50% |
5 Analysts have issued a sales forecast Gyre Therapeutics Inc 2026 . The average Gyre Therapeutics Inc sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Gyre Therapeutics Inc EBITDA forecast 2026. The average Gyre Therapeutics Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Gyre Therapeutics Inc Analysts have issued a net profit forecast 2026. The average Gyre Therapeutics Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2031
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.05 | -0.38 |
| 58.33% | 860.00% | |
| P/E | negative | |
| EV/Sales | 6.08 |
5 Analysts have issued a Gyre Therapeutics Inc forecast for earnings per share. The average Gyre Therapeutics Inc EPS is
This results in the following potential growth metrics and future valuations:
Gyre Therapeutics Inc...
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
